2i0j: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2i0j.png|left|200px]] | [[Image:2i0j.png|left|200px]] | ||
{{STRUCTURE_2i0j| PDB=2i0j | SCENE= }} | {{STRUCTURE_2i0j| PDB=2i0j | SCENE= }} | ||
===Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia=== | ===Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia=== | ||
{{ABSTRACT_PUBMED_17034120}} | {{ABSTRACT_PUBMED_17034120}} | ||
==About this Structure== | ==About this Structure== | ||
[[2i0j]] is a 4 chain structure of [[Estrogen receptor]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I0J OCA]. | |||
==See Also== | |||
*[[Estrogen receptor|Estrogen receptor]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:017034120</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Wang, Y.]] | [[Category: Wang, Y.]] | ||
[[Category: Nuclear receptor ligand binding domain]] | [[Category: Nuclear receptor ligand binding domain]] | ||
[[Category: Transcription]] | |||
Revision as of 00:27, 27 July 2012
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia
Template:ABSTRACT PUBMED 17034120
About this Structure
2i0j is a 4 chain structure of Estrogen receptor with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. J Med Chem. 2006 Oct 19;49(21):6155-7. PMID:17034120 doi:10.1021/jm060491j
